About
Kris Verburgh is a medical doctor and Partner and Head of Science at the BOLD Longevity Growth Fund, which invests in biotechnologies aimed at slowing aging. He previously held the same role at the Longevity Vision Fund, a $100 million fund that has since closed to new investments, and co-founded NOVOS, a nutraceutical targeting nine hallmarks of aging. He has written four books, including "The Longevity Code," which addresses nutrition and biotechnology in relation to aging and health.
Experience
- BOLD Longevity Growth FundPartner & Head of Sciencecurrent2023 — presentBoston, Massachusetts, United States
- Singularity UniversityExpert - Medicine, Biotech and Longevitycurrent2016 — present
- Vrije Universiteit BrusselScientific Researcher - Future of Medicine and Longevitycurrent2014 — present
- Vrije Universiteit BrusselMember Evolution, Complexity and Cognition Group (ECCO)current2014 — present
- Consultations & Longevity Concierge ServicesMedical doctor (MD)current2011 — present
- Speakers Academy®Speaker / Panelistcurrent2004 — present
- HarperCollins Publishers & PrometheusAuthorcurrent2003 — presentLondon - New York
- Longevity Vision FundPartner & Head of Science2019 — 2023New York, United States
- NOVOSCo-Founder2019 — 2023New York, United States
- Voeding LeeftMember Advisory Board 'Voeding Leeft' ('Nutrition Lives')2015 — 2018
Skills & more
Public Speaking14Management1Medicine19Metabolism2Biotechnology9Science42Lifesciences9Neuroscience35Research27Statistics3Molecular Biology5Preventive Medicine6
+12 more
EntrepreneurshipBloggingTeachingNutritionCancerNeurologyCell BiologyCoachingBusiness StrategyLife SciencesEnglishInnovationLanguages Dutch · English · French · German · Spanish
From Kris's professional profile.
Colleagues at Bold Capital Partners
Avik Arakelian
Partner BOLD Longevity at Bold Capital Partners
Daglar Cizmeci
Venture Partner at Bold Capital Partners
Emilio Diez Barroso
General Partner at Bold Capital Partners
Felicia Hsu
Principal at Bold Capital Partners
Gunner Hardy
Associate BOLD Longevity at Bold Capital Partners
Helen McBride
Partner at Bold Capital Partners
Henry Shi
Venture Partner at Bold Capital Partners
Matt Grob
Venture Partner at Bold Capital Partners
Frequently asked questions
- Who is Kris Verburgh?
- Kris Verburgh is a medical doctor and Partner and Head of Science at the BOLD Longevity Growth Fund, which invests in biotechnologies aimed at slowing aging. He previously held the same role at the Longevity Vision Fund, a $100 million fund that has since closed to new investments, and co-founded NOVOS, a nutraceutical targeting nine hallmarks of aging. He has written four books, including "The Longevity Code," which addresses nutrition and biotechnology in relation to aging and health.
- Where does Kris Verburgh work?
- Kris Verburgh is Partner BOLD Longevity at Bold Capital Partners.
- Where did Kris Verburgh go to school?
- Kris Verburgh studied at Vrije Universiteit Brussel (Research (new developments in medicine, biotechnology and longevity)); University of Antwerp (Medicine); Sint-Jan Berchmans Institute (Science and mathematics).
Same school
Also attended Vrije Universiteit Brussel28
Kris VerburghPartner & Head of Science at BOLD LongevityAnne Cathrine WilhjelmAttorney, Partner at SEED Capital DenmarkYuhua BaiAccounting Officer at Astanor VenturesFilip KegelsOperational Partner at Astanor VenturesRuben PauwelsInvestor at AngelwiseCynthia Verswijvel-CornelissenBestuurder at Angelwise
+ 22 more
Also attended University of Antwerp46
Jan AvontsInvestment Director at Capricorn Venture PartnersWim Van LooverenFinance Director at Heran PartnersJoris MortelmansPartner & Senior Advisor at Heran PartnersKris VerburghPartner & Head of Science at BOLD LongevityChris ThoenChairman of the Scientific Advisory Board & IC Member (PeakBridge Growth II) at PeakBridge VCJohan van MilTeam member at Peak, an early-stage fund backed by entrepreneurs
+ 40 more
Shared employers
Also worked at Singularity University50
Marco DeMirozGeneral Partner & Co-founder at The Venture Reality FundLindsey YeePrincipal at Starbridge Venture Capital LlcMatthew Le MerleManaging Partner & CEO at Blockchain CoinvestorsPeter DiamandisPhysician, entrepreneur, and futurist inspiring leaders to think exponentially and create a future of abundanceKris VerburghPartner & Head of Science at BOLD LongevityPatricia Chin-SweeneyVenture Partner at Beyond Capital Ventures
+ 44 more
Also worked at Vrije Universiteit Brussel9
Kris VerburghPartner & Head of Science at BOLD LongevityNikos DeligiannisMachine learning | Data | Tech at AngelwisePieter WellensTech | Software at AngelwiseRoel CallebautSenior Investment Manager at FinindusJohan BrantsAdvisory Board Expert at Qbic FundPhilippe StasInvestor at White Fund
+ 3 more
Also worked at HarperCollins Publishers & Prometheus8
Andrew ChenGeneral Partner at Andreessen HorowitzKris VerburghPartner & Head of Science at BOLD LongevityBetsy ForeFounding Partner, Velveteen Ventures at xfactor venturesSuzanne KellyCEO of Cipher Brief at New North VenturesLeland MelvinVenture Partner at Pier 70 VenturesScott HartleyFounder & General Partner at Everywhere Ventures
+ 2 more
Also worked at Longevity Vision Fund7
Sergey YoungCo-Founder at BOLD LongevityKris VerburghPartner & Head of Science at BOLD LongevitySun AltbachSenior Scientific Advisor at BOLD LongevityGunner HardyAssociate at BOLD LongevitySergey YoungCo-Founder BOLD Longevity at Bold Capital PartnersSun AltbachSenior Advisor BOLD Longevity at Bold Capital Partners
+ 1 more



























.png)















